Net Cash Provided by (Used in) Operating Activities |
-1.78M |
USD |
-138% |
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
0 |
USD |
|
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-36.5K |
USD |
-136% |
Q4 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
21.6M |
shares |
0% |
Q4 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
3.5M |
shares |
+0.17% |
Q4 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
3.47M |
USD |
+176% |
Q4 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
3.04M |
USD |
-14.6% |
Q4 2024 |
Q1 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
1.25K |
USD |
-95.8% |
Q4 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q3 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
430K |
USD |
+5.17% |
Q3 2024 |
FY 2024 |
Payments to Acquire Property, Plant, and Equipment |
37.3K |
USD |
|
Q4 2024 |
Q1 2025 |
Property, Plant and Equipment, Gross |
7.36M |
USD |
-16.6% |
Q4 2024 |
Q1 2025 |
Deferred Income Tax Expense (Benefit) |
-207K |
USD |
-328% |
Q4 2024 |
Q1 2025 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q4 2024 |
Q1 2025 |
Additional Paid in Capital |
796K |
USD |
+4.01% |
Q4 2024 |
Q1 2025 |
Deferred Tax Assets, Net of Valuation Allowance |
430K |
USD |
+5.17% |
Q3 2024 |
FY 2024 |
Interest Expense |
379K |
USD |
+65.2% |
Q4 2023 |
Q1 2024 |